Adriamycin (Doxorubicin)

Photograph of Adriamycin (Doxorubicin) under the microscope.

Adriamycin is the common name for the drug doxorubicin hydrochloride that is thought to bind DNA and inhibit nucleic acid synthesis. The drug has been used to successfully produce regression in disseminated neoplastic situations. Examples are acute lymphoblastic leukemia, acute myeloblastic leukemia, Wilm's tumor, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, and many others ailments. The dosage needs to be closely monitored because this drug can cause irreversible cardiac damage. Other side effects include hair loss, sores on the mouth and lips, and a darkening of the skin.

© 1995-2022 by Michael W. Davidson and The Florida State University. All Rights Reserved. No images, graphics, software, scripts, or applets may be reproduced or used in any manner without permission from the copyright holders. Use of this website means you agree to all of the Legal Terms and Conditions set forth by the owners.
This website is maintained by our
Graphics & Web Programming Team
in collaboration with Optical Microscopy at the
National High Magnetic Field Laboratory.
Last modification: Monday, Jul 02, 2018 at 04:22 PM
Access Count Since April 15, 1997: 74194